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Abstract
Background: Primary Care Health organizations, operating under universal coverage and a regulated package of
benefits, compete mainly over quality of care. Monitoring, primary care clinical performance, has been repeatedly
proven effective in improving the quality of care. In 2004, Maccabi Healthcare Services (MHS), the second largest
Israeli HMO, launched its Performance Measurement System (PMS) based on clinical quality indicators. A unique
module was built in the PMS to adjust for case mix while tailoring targets to the local units.
This article presents the concept and formulas developed to adjust targets to the units’ current performance, and
analyze change in clinical indicators over a six year period, between sub-population groups.
Methods: Six process and intermediate outcome indicators, representing screening for breast and colorectal cancer
and care for patients with diabetes and cardiovascular disease, were selected and analyzed for change over time
(2003–2009) in overall performance, as well as the difference between the lowest and the highest socio-economic
ranks (SERs) and Arab and non-Arab members.
Results: MHS demonstrated a significant improvement in the selected indicators over the years. Performance of
members from low SERs and Arabs improved to a greater extent, as compared to members from high ranks and
non-Arabs, respectively.
Conclusion: The performance measurement system, with its module for tailoring of units' targets, served as a
managerial vehicle for bridging existing gaps by allocating more resources to lower performing units. This concept was
proven effective in improving performance while reducing disparities between diverse population groups.
Keywords: Public health, Quality improvement, Quality measurement, Quality indicators
Background
Healthcare organizations operating under universal cover-
age, regulated prices and package of benefits compete
mainly over quality of care and patient satisfaction [1, 2].
Monitoring clinical performance measures by large
healthcare organizations has been repeatedly proven
effective in improving the quality of care [3–6]. How-
ever, measurement alone is insufficient for improving
quality. The Veteran Affairs (VA), for example, devel-
oped and maintained valid and cost-effective mea-
sures, but still demonstrates considerable variability in
levels of performance across measures and facilities, sug-
gesting the need for effective feedback to providers [7].
Achieving equity in health care is an important goal of
most primary health care systems and reforms. Although
primary health care plays an important role in improving
health equity [8], international evidence shows that en-
hancement of primary primary healthcare services for
vulnerable individuals (e.g. low income, diverse racial
and ethnic populations) critical but not enough for redu-
cing health and health care inequities [9–11]. Measuring
and monitoring equity in healthcare settings remain
challenging mainly because current primary healthcare
indicators and measures do not adequately reflect orga-
nizations’ efforts to provide primary care services to
groups most affected by structural inequities [12].
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The VA has questioned the adequacy of their monitor-
ing system using a "treat to target" method, which focuses
on attainment of specific risk factor thresholds, in achiev-
ing control, in a diverse population. This concern has led
the VA to develop a system that is based on “tightly
linked” clinical action measures, in which the process spe-
cified by the measure is strongly tied to the evidence. Spe-
cifically, clinical action measures focus not only on the
risk factor level but also give credit to the process [13]. In
other healthcare systems, where performance is measured,
a concern has been raised, that the results may account
for differences in patient characteristics [14–16].
Research usually distinguishes between equality and
equity in the provision of care and health outcomes:
health equity is defined as the absence of systematic and
potentially remediable differences in one or more char-
acteristics of health across populations or population
groups which are socially, economically, demographically
or geographically defined [17]; whereas equality in health
care means equal access, treatment and treatment out-
comes for people of equal need [18]. These distinctions
are important in developing equity-oriented indicators,
given the widening inequities in health and social status.
The Israeli population is highly diverse. Twenty per-
cent are Israeli Arabs who live mainly in rural settle-
ments and mixed cities, and like all Israeli citizens, they
are fully insured by the National Health Insurance Law
under a universal care system. Eighteen percent of the
Israeli population are considered "poor" with a 0.363
Gini Index for inequality in household income for
2013 [19]. Therefore, all Israeli health maintenance
organizations (HMO) are challenged by this diversion,
and are forced to invest in reducing inequalities and
inequities.
This article has two objectives: 1) to describe the con-
cept and implementation of a unique module, which ad-
justs performance targets for current achievements, in
order to compensate for different case mixes and
population diversion; and 2) to present an analysis of the
effect of this concept on care quality and equity.
Setting
This study was initiated by Maccabi Healthcare Services
(MHS), the second largest Israeli health plan (HMO),
that provides primary and secondary community-based
services to two million beneficiaries. These services are
provided to diverse population groups country-wide,
through five regions, divided into 150 branches (the
basic administrative unit). Services are based on a core
staff of 8,000 physicians, including 2,000 primary care
physicians, 1,200 nurses and other health professionals.
Physicians are normally self-employed who work in
MHS' clinics or in their private clinics with seventeen
million encounters (in 2013). In-patient care is pur-
chased by the MHS from local medical centers.
Nine percent of MHS members are categorized in the
lowest quartile of socioeconomic status, while 25.6% are
in the upper quartile. Seven percent of MHS members are
Israeli Arabs who are entitle for a full healthcare coverage.
Performance Measurement System (PMS)
In 2004 MHS launched a Performance Measurement Sys-
tem (PMS), aiming to improve quality of care by monitor-
ing and internally reporting on clinical performance.
Twenty-five process and intermediate outcome indicators
represented six clinical domains: early detection of cancer
(colon and breast); influenza and pneumococcal vaccin-
ation; early detection of risk factors and treatment for
cardio-vascular diseases; diabetes care; diagnosis and treat-
ment of depression; and appropriate use of antibiotics.
Each indicator definition was based on the National
Program for Quality Indicators in Community Health-
care's definitions [20], which in turn was based on the
Healthcare Effectiveness Data and Information Set
(HEDIS) indicator set [3]. Indicators’ definitions are pre-
sented in Table 1. A steering committee consisted on:
Table 1 Selected quality indicators and target populations*
Type of Care Criteria for Meeting Quality Standards Target Population in 2009 (N)
Mammography Subjects: Females aged 52–74 with no history of cancer.
Criterion: A mammography performed within the last 24 months.
153,785
Colorectal cancer screening Subjects: Adults aged 51–74 with no history of cancer.
Criterion: an FOBT†† within the last 12 months or a colonoscopy
within the last 5 years
308,929
HbA1C Performance Subjects: Adults recorded in the diabetes registry
Criterion: HbA1C performed at least once during the last 12 months
77,898
Diabetes adequate control Subjects: Adults recorded in the diabetes registry
Criterion: HbA1C < 7 gr%, last test
77,898
Diabetes poor control Subjects: Adults recorded in the diabetes registry
Criterion: HbA1C > 9 gr%, last test.
77,898
Adequate control of LDL cholesterol,
patients with CVD
Subjects: Adults recorded in the cardio-vascular disease registry
Criterion: LDL < 100 mg%, last test
54,095
*Indicators were defined by MHS performance system in accordance with the National Quality Indicator Program's definitions
Peled et al. BMC Health Services Research  (2016) 16:668 Page 2 of 6
physicians; IT experts; central and regional quality man-
agement representatives evaluated the definitions which
were finally approved by the organizational chief executive
officer (CEO) and chief medical officer (CMO).
The core of the PMS is a unique module, built into
the system, which allows setting tailor-made benchmarks
for each of MHS' administrative units (regions and
branches). The system produces monthly reports, which
are distributed in a transparent manner to local man-
agers. The reports reflect each unit's gaps between
achieved and desired targets.
Programming
MHS is a fully computerized healthcare organization: all
diagnoses, prescriptions, diagnostic tests and billings are
stored in a central data warehouse, from which the PMS
retrieves information. A Microsoft Performance Point
Server acts as a mediating platform supporting the inte-
gration of data, reports and explanatory documents.
Setting units' tailor-made targets
The main objective of setting tailor-made targets, was to
continually support and encourage the successful units
but also to help and push, for better achievements, the
weaker units.
For each clinical indicator, MHS has defined an upper
benchmark ("ultimate goal"), which is the level of perform-
ance MHS aims to achieve within a 3–5 year period. For
every given year, an organizational target is set, based on
prior progress towards the upper benchmark and an esti-
mation of resources and capabilities. A unique mechanism
helps to adjust a tailor-made unit target, taking into
account the unit’s diverse member populations and their
socio-economic; personal and social characteristics.
Weighted unit's grades (UGs) for all indicators are
calculated and contribute to the unit's "overall grade"
for the purpose of recognition and modest reward.
This was done as follows:
Step 1. Formulating an indicator factor (IF): Since
each indicator demonstrates a different range of per-
formance, we formulated a factor for each indicator (i),
calculated yearly as follows:
IFi ¼ MHS0 annual target – end of previous year MHS performanceð Þ
MHS0 ultimate goal − end of previous year performanceð Þ
Step 2. Calculating the unit target, using the follow-
ing formula for each clinical indicator:
UTi = IFi *(MHS' upper benchmark - the unit's last
year† performance) + the unit's last year† performance
(† December 31).
Step 3. Calculating a Unit's Grades (UG)
UGi = (0.3 *% of achieving the upper benchmark)
+ (0.7 *% of achieving the tailor-made target). These
rates (30% and 70%) were assigned based on the idea
to encourage excellence beyond the tailored targets.
For example: MHS's upper benchmark (for the next
3–5 years) for mammography screening was 80%; MHS'
target for the upcoming year is assigned to 70%; MHS'
end of last year performance was 60%.
Mammography IF ¼ 70–60ð Þ ¼ 0:5
80–60ð Þ
The unit's last year performance in Mammography
screening was 50%
UT mammography ¼ 0:5 80–50ð Þ þ 50 ¼ 65%
UG mammography ¼ 0:3 65=80ð Þ þ 0:7 65=65ð Þ
¼ 0:94
Reports and rewards
Performance data at the branch (unit), region and
organization levels were distributed monthly to all man-
agers and caregivers. Quarterly and yearly reports ana-
lyzed temporal trends and gaps in performance between
units serving different sub-populations. These same re-
ports were used to identify the need for process re-
design, and to encourage the design of tailor-made local
interventions [21].
Rewards were mainly based on organizational ac-
knowledgements to managers who achieved higher
scores. Every year, in an organizational managerial con-
ference, these managers were publicly announced. There
were no sanctions on those branches who did not meet
the desired scores, however, there was a managerial
pressure to improve performance.
Methods
Analyzing trends in clinical performance and between
sub population groups
Measurements
In order to evaluate changes in performance over time,
six indicators, for which definitions were not changed
over time stable and each patient's data was fully re-
corded, were selected: 1) mammography; 2) colorectal
cancer screening; 3) HbA1C performance; 4) diabetes
adequate control; and 5) diabetes poor control (Table 1).
These indicators were compared for the years 2003–2009
and analyzed for members' socio-economic and ethnic
characteristics (Israeli Arabs and Israeli non-Arabs).
Statistical methods
For each indicator, rates were calculated by dividing the
number of eligible patients who utilized the service or
achieved the treatment goal by the number of those who
met the eligibility criteria for the service.
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To assess the significance of the trends over time
(2003–2009), we estimated linear regression models for
curve fit for each of the selected indicators.
The Curve Estimation procedure generates a time
variable in which the period of time between cases is
uniform. If Time is selected, the dependent variable
should be a time-series measure. Time-series analysis
requires a data file structure, in which each case
(row) represents a set of observations at different
times, and the period of time between cases is uni-
form [22].
Dependent variable: each indicator’s rate.
Independent Variable: Socio-Economic Rank (SER)
and ethnicity: Israeli Arabs vs. non-Israeli Arabs
Socio-Economic Rank (SER) was defined by the rank
(1–20 scale) of members' area of residence (based on Is-
raeli Census Bureau data), and then categorized into the
lowest (1–5) and highest (16–20) categories [23].
Ethnicity: Since Israeli HMOs do not have access to
personal ethnicity data, Israeli Arabs were identified by
the ethnicity of their residence as recorded in the Na-
tional Census [23].
Results
The study population (2009) ranged between 153,785
mammography eligible women and 54,095 adults diag-
nosed with cardiovascular disease (CVD) who were tar-
geted for decreasing LDL cholesterol (Table 1).
Overall organizational performance demonstrated con-
siderable improvement over the years, which was statis-
tically significant in all indicators except for adequate
diabetes control (Table 2). The most considerable im-
provement over time was demonstrated by colorectal
screening (147% from 2004 to 2009) and adequate LDL
control in patients with cardio-vascular disease (90% im-
provement during the study period).
Performance of lowest SER members improved to a
larger extent in comparison to members from highest
SERs in all measures except for blood examination of
HbA1C levels. As a group, members of Arab ethnicity
achieved a larger relative improvement in comparison to
non-Arab members (Table 3).
Discussion
The first objective of this article is to describe a
unique module built-in the performance measurement
system, for setting tailor-made targets per unit. The
allocation of these targets intended to adjust for the
current level of performance, which in turn reflected
the case mix of the units, as well as their personal
and social characteristics to improve care. By expect-
ing units with lower levels of performance to achieve
a larger absolute (and relative) improvement, the mes-
sage to regional managers was a demand to allocate
more resources to the weaker branches, in order to
gradually close the gap. This in turn was transmitted
to front-line caregivers. A request to provide special
attention to less achieving units pushed the formula-
tion of local solutions to overcome barriers that po-
tentially prevented weaker populations from achieving
optimal health outcomes. An example of such a pro-
ductive local activity, supported by organizational in-
frastructures, is the case of increasing breast cancer
screening among Arab women [21]. The managerial
demand for preferential allocation of resources to the
weak units was effective in reducing some of the dis-
parities in health measures. In fact, the module of tai-
lored targets resulted in "lifting the floor rather than
pushing up the ceiling". Putting more emphasis on
the relative improvement of weaker units was also
reflected, as allocated in the scoring formula, to a
greater extent, to the units for achieving their tailor-
made target - i.e., for making a greater relative
improvement (0.7 of the score for each indicator).
However, in order to praise excellence as well, high
absolute performance was also rated, although to a
lesser extent (0.3 of the score).
The second objective of this article was to present ana-
lysis of the effect of the above described concept, on care
quality and equity. From the year 2003 to 2009, most of
the selected quality indicators demonstrated a significant
and steady improvement. Of special value is the finding
that members who lived in low socioeconomic neighbor-
hoods or in Arab settlements/local authorities achieved
a relatively larger improvement, in comparison with
members of higher socioeconomic groups or non-Arabs.
Table 2 Performance rates (%) for Selected Clinical Indicators, 2003–2009
Indicator 2003 2004 2005 2006 2007 2008 2009 P for Time Trend
Mammography 51.3 52.7 63.1 67.7 65.3 70.6 73.8 0.001
Colorectal cancer screening NMa 15.6 19.0 27.7 30.4 33.6 38.5 <0.001
HbA1C Performance NM 89.7 90.2 91.6 91.7 91.3 93.1 <0.001
Diabetes adequate control 53.2 46.7 56.0 54.6 55.9 59.6 59.7 0.035
Diabetes poor control NM 13.0 11.1 11.7 11.1 9.3 9.2 0.010
Adequate LDL control in patients with cardio-vascular disease 33.0 35.9 45.9 56.3 59.6 61.6 62.8 0.001
aNM: Not measured
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Over the years, MHS has paid attention to and
invested resources in care quality improvement. This
was done by sending a clear managerial message, distrib-
uted by the target-based measurement system. Transpar-
ency of performance, frequent internal reporting and
competition over recognition and modest rewards (add-
itional budgets for social events for the unit's staff ), all
contributed to a clear unequivocal organizational "voice".
This message was facilitated by MHS' Quality Infra-
structure, consisting of a central quality body, as well as
multidisciplinary "quality teams" at the regional and
branch levels. Teams were provided with training, tools
and a framework for organizational learning from across
units while implementing quality improvement initia-
tives such as breast cancer prevention program among
Arab women [21].
It should be noted that tailoring of targets is only
one, and definitely not the sole mechanism, for improv-
ing equity of health care and health outcomes. Experi-
encing success in some reduction of disparities indeed
created organizational discourse on equity and equality
issues, and raised top managerial concern and belief
that this might be feasible. From a long-term perspec-
tive, implementation of the measurement system has
made "quality" integral to the MHS organizational dis-
course. This dialogue, supported by a set of validated
data, has contributed a new "language". Terms like
quality gap, data analysis, prioritization of domains for
intervention, effective methods for improvement and
reduction of health disparities have all helped create a
new organizational culture within MHS. Medical direc-
tors, as well as nonmedical administrators, all perceived
quality improvement as a crucial element in their role
definitions. Quality issues have consequently captured
an increasing portion of the managerial dialogue
conducted with primary care physicians and other
health professionals.
Performance measuring systems are used in many
health organizations around the world. To illustrate,
the American Veterans Affairs (VA) healthcare system,
has undergone various transformations in an attempt to
improve quality of care, including implementation of per-
formance measurement, focusing on high-priority condi-
tions such as diabetes and coronary artery disease. In
earlier published studies, the VA reported a steady and sig-
nificant increase in all the selected measures [24–27], in-
cluding higher performance levels, when compared with
non-VA settings [4, 27]. However, the VA reported that
despite the improvement in quality of care, racial disparity
persists for important Clinical Outcomes [27]. Our statis-
tical analysis reveal that, disparities between sub popula-
tion groups, in the presented clinical measurements, were
reduced. It is for sure, that the way we weighed unit's per-
formance and encouraged them to take bold steps and in-
vest in intervention program, to close gaps, has to do with
this reduction, although no statistical model could esti-
mate for this unique formula as an independent variable.
Our positive statistical findings should take several
limitations into consideration:
First: the lack of a control group. The PMS was initi-
ated as an organizational system which covers all units.
As a result, there are no units that can serve as a control
group. What we can see, are the differences between
units and subpopulation groups, in performance and
intermediate outcomes, for which the tailored targets try
to compensate and adjust.
Second, due to technical barriers such as the insuffi-
cient timely flow of hospital data on health outcomes,
we were limited to the use of process and intermediate
outcomes to evaluate the quality of care provided to
MHS members. The use of long-term outcome mea-
sures, such as rate of amputations among diabetics or
disease-related mortality, was precluded.
Third, most quality indicators are sensitive to pa-
tient characteristics for their validity [28]. Israeli
HMOs face legal constraints on the collection of se-
lected types of personal socio-demographic data, such
as income or ethnicity. We therefore used proxies,
such as the rank of the geographic statistical index
of the members' area of residence. And third, a de-
sign of case control study would have provide a bet-
ter understanding the association between the PMS
and the health outcomes observed here. However, the
Israeli healthcare system, which is universal insist, by
law, on equity and equality. Thus, there is no way to
provide unequal services just for the sake of the
research.
Fourth: we analyzed six indicators, for which the defi-
nitions has not been changed over time and the patient's
Table 3 Percent change, 2003 to 2009, by SER and ethnicity
Indicator SER 1–5 SER 16–20
Mammography 40.0 29.0
Colorectal cancer screening 77.0 55.0
HbA1C Performance −35.0 10.0
Diabetes adequate control 13.0 10.0
Diabetes poor control −40.0 −51.0
Adequate LDL control in cardio-vascular patients 35.0 31.0
Indicator Arabs Non Arabs
Mammography 56.0 41.0
Colorectal cancer screening 89.0 65.0
HbA1C Performance 11.0 9.0
Diabetes adequate control 20.0 12.0
Diabetes poor control −37.0 −57.0
Adequate LDL control in cardio-vascular patients 37.0 33.0
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information was fully recorded. These indicators do not
necessary represent the other indicators.
Conclusion
The Performance Measurement System described in this
article, with its unique built in formulas, adjusting for
the relative level of performance, has a potential of serv-
ing as a locomotive, pulling the quality system toward its
goals. The concept of management by assigning tailor-
made targets to healthcare services units and rewards
for achieving those targets, proved effective in improving
care, while reducing disparities.
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